| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 5.9e-05 | 1 |